Niagen Bioscience (NAGE) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to $0.05.
- Niagen Bioscience's EPS (Weighted Average and Diluted) rose 15000.0% to $0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.24, marking a year-over-year increase of 230000.0%. This contributed to the annual value of $0.11 for FY2024, which is 26618.79% up from last year.
- As of Q3 2025, Niagen Bioscience's EPS (Weighted Average and Diluted) stood at $0.05, which was up 15000.0% from $0.04 recorded in Q2 2025.
- Niagen Bioscience's EPS (Weighted Average and Diluted)'s 5-year high stood at $0.09 during Q4 2024, with a 5-year trough of -$0.13 in Q3 2021.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.02, with a median of -$0.01 in 2022.
- Per our database at Business Quant, Niagen Bioscience's EPS (Weighted Average and Diluted) plummeted by 8571.43% in 2021 and then skyrocketed by 2024906.67% in 2025.
- Quarter analysis of 5 years shows Niagen Bioscience's EPS (Weighted Average and Diluted) stood at -$0.08 in 2021, then surged by 73.87% to -$0.02 in 2022, then soared by 107.34% to $0.0 in 2023, then surged by 5944.26% to $0.09 in 2024, then plummeted by 45.59% to $0.05 in 2025.
- Its last three reported values are $0.05 in Q3 2025, $0.04 for Q2 2025, and $0.06 during Q1 2025.